You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

H3B-6545

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

Active, not recruiting
  • Breast Neoplasms
  • +7 more
  • H3B-6545
  • Goodyear, Arizona
  • +38 more
Jun 29, 2022

CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

Not yet recruiting
  • Central Nervous System Neoplasms
  • +6 more
  • B7-H3-CAR T cells
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 18, 2023

Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)

Recruiting
  • Brain Gliomas
  • Allogenic B7H3 CAR-γδT cell
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Aug 25, 2023

Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)

Recruiting
  • Glioblastoma Multiforme
  • CAR.B7-H3T cells infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 25, 2022

Brain and Nervous System Trial in Palo Alto (B7-H3CART)

Recruiting
  • Brain and Nervous System
  • Palo Alto, California
    Stanford Cancer Institute
Jul 22, 2022

The Role of B7-H4 in Tumor Vaccine

Recruiting
  • Glioma
  • tumor vaccine
  • Shanghai, Shanghai, China
    Di Chen
Nov 26, 2023

Advanced Glioma, Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy Trial in Suzhou (Targeted IL-13 Ra2 UCAR-T cell

Recruiting
  • Advanced Glioma
  • Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
  • Targeted IL-13 Rα2 UCAR-T cell injection
  • Targeted B7-H3 UCAR-T cell injection
  • Suzhou, Jiangsu, China
    The Second Affiliated Hospital of Soochow University
Mar 2, 2023

Soluble B7-H3 as a Biomarker for Osteosarcoma

Recruiting
  • Biomarker
  • +3 more
  • ELISA: enzyme-linked immunosorbent assay
  • Beijing, Beijing, China
    Peking University People's Hospital
Jul 5, 2023

Recurrent Glioblastoma, Refractory Glioblastoma Trial in Hangzhou, Huzhou, Ningbo (Temozolomide, B7-H3 CAR-T)

Recruiting
  • Recurrent Glioblastoma
  • Refractory Glioblastoma
  • Hangzhou, Zhejiang, China
  • +2 more
Dec 25, 2022

Advanced Solid Tumor Trial in Lianyungang (KT095 CAR-T injection)

Not yet recruiting
  • Advanced Solid Tumor
  • KT095 CAR-T injection
  • Lianyungang, Jiangsu, China
    Lianyungang First People's Hospital
Aug 23, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

Children After Hospitalization in Intensive Care Unit

Not yet recruiting
  • Renal Disease
  • +7 more
  • neurocognitive tests
  • Calgary, Alberta, Canada
  • +7 more
Nov 3, 2023

EGFR/ B7H3-positive Advanced Lung Cancer, EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer Trial in Guangzhou

Recruiting
  • EGFR/ B7H3-positive Advanced Lung Cancer
  • EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer
  • EGFR/B7H3 CAR-T
  • Guangzhou, Guangdong, China
    Second Affiliated Hospital of Guangzhou Medical University
Apr 18, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

B7-H3-positive Relapsed/ Refractory Neuroblastoma Trial in Tianjin (T cell injection targeting FLT3 chimeric antigen receptor)

Not yet recruiting
  • B7-H3-positive Relapsed/ Refractory Neuroblastoma
  • T cell injection targeting FLT3 chimeric antigen receptor
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Nov 1, 2022

Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

Not yet recruiting
  • Bipolar Disorder
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2023

IBD, Crohn's, Ulcerative Colitis Trial in Canada

Recruiting
  • Inflammatory Bowel Diseases
  • +2 more
    • Calgary, Alberta, Canada
    • +11 more
    Nov 30, 2022

    Anesthesia Trial in Halifax, Montréal (memsorb)

    Recruiting
    • Anesthesia
    • memsorb
    • Halifax, Nova Scotia, Canada
    • +1 more
    Nov 18, 2022

    Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • (no location specified)
    Sep 20, 2023

    Advanced Hepatocellular Carcinoma, Hepatocellular Carcinoma, Liver Cancer Trial in Worldwide (H3B-6527)

    Completed
    • Advanced Hepatocellular Carcinoma
    • +5 more
    • Los Angeles, California
    • +43 more
    Apr 5, 2022

    Hepatocellular Carcinoma Trial in Xuzhou (fhB7H3.CAR-Ts, Fludarabine, Cyclophosphamide)

    Recruiting
    • Hepatocellular Carcinoma
    • fhB7H3.CAR-Ts
    • +2 more
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Apr 5, 2022

    Novel Functional Eye-Tracking Software Application for Multiple

    Recruiting
    • Multiple Sclerosis
    • Eye-Tracking
    • Montreal, Quebec, Canada
    • +1 more
    Dec 14, 2022

    Sleep Apnea Trial in Halifax (NovaResp MAPR System)

    Not yet recruiting
    • Sleep Apnea
    • NovaResp MAPR System
    • Halifax, Nova Scotia, Canada
      Sleep Disorders Clinic
    Aug 14, 2023

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

    Suspended
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 20, 2023